Post job

Bioniz Therapeutics executives

Here are further demographic highlights of the leadership team:
  • The Bioniz Therapeutics executive team is 13% female and 87% male.
  • 56% of the management team is White.
  • 11% of Bioniz Therapeutics management is Hispanic or Latino.
  • 9% of the management team is Black or African American.
Work at Bioniz Therapeutics?
Share your experience

Rate Bioniz Therapeutics' leaders' effectiveness in guiding the company.

Zippia waving zebra
Name & TitleBio
Nazli Azimi

Board Member

Nazli Azimi's LinkedIn

Scientist CEO with track record launching 2 successful biotech companies. Talent for translating scientific discovery into commercial opportunity with “pipeline in a product” strategy to create blockbuster market opportunities. Deep scientific knowledge in immunology, cancer, autoimmune/inflammatory diseases, and neuroimmunology. Dynamic and sought-after public speaker.» Guiding discovery teams to prioritize efforts in identifying attractive targets for creating highly valuable drug candidates.» Navigating the crowded intellectual property landscape and securing IP.» Raising funds from seed to institutional investors and strategic partners.» Negotiating licensing and M&A deals.» Understanding the FDA regulatory pathways and guiding interactions with the agency. » Attracting top talent to the executive and scientific teams and building a dynamic and fun culture.» Working effectively across finance, audit, clinical, and technical teams as well as board of directors.CREDENTIALS:➢ PharmD, PhD ➢ Post-doctoral fellowship in Immunology at the National Institutes of Health with a focus on cytokine biology. ➢ Author of over 30 peer-reviewed publications in the areas of immunology, oncology, virology, and neurological disease. ➢ Co-inventor of Bioniz platform technology that covers over 45 patents EXECUTIVE AND FOUNDER OF 2 SUCCESSFUL BIOTECH COMPANIES:» Charted the roadmap for product development, operations, and marketing for Dermaheal USA Corp, » Co-invented novel platform technology for Bioniz Therapeutics and led the clinical development for its assets. Recruited top talent, raised capital, and closed M&A deal for its first asset. . Board member since company’s inception.CORE VALUES:★ Entrepreneurship★ Innovation★ Integrity★ Perseverance★ Collaboration★ Growth★ DiscoveryRESEARCH SPECIALTIES: Immunology | Cancer | Autoimmune | Inflammatory Disease | Cytokine Inhibitors | Peptide TherapiesScientific discovery | IP Strategy | Market Feasibility | Team Leadership | FDA Approvals | Clinical Trials | Team Building | Corporate Structure | Company Culture | Research & Development | Fundraising | M&A Negotiations | Regulatory Pathways | Patent Filings

Yutaka Tagaya

Scientific Co-Founder

David Pyott

Chairman of The Board

Joe Kiani

Board Member

Alexandre Kaoukhov

SVP and Head of Clinical Development

Eric Carter

Board Member

Kevin Green

SVP of Corporate Development

Michael Martin

Board Member

Bana Jabri

Board Member

Graham Cooper

Board Member

Do you work at Bioniz Therapeutics?

Does the leadership team provide a clear direction for Bioniz Therapeutics?

Bioniz Therapeutics jobs

Bioniz Therapeutics founders

Name & TitleBio
Nazli Azimi

Board Member

Nazli Azimi's LinkedIn

Scientist CEO with track record launching 2 successful biotech companies. Talent for translating scientific discovery into commercial opportunity with “pipeline in a product” strategy to create blockbuster market opportunities. Deep scientific knowledge in immunology, cancer, autoimmune/inflammatory diseases, and neuroimmunology. Dynamic and sought-after public speaker.» Guiding discovery teams to prioritize efforts in identifying attractive targets for creating highly valuable drug candidates.» Navigating the crowded intellectual property landscape and securing IP.» Raising funds from seed to institutional investors and strategic partners.» Negotiating licensing and M&A deals.» Understanding the FDA regulatory pathways and guiding interactions with the agency. » Attracting top talent to the executive and scientific teams and building a dynamic and fun culture.» Working effectively across finance, audit, clinical, and technical teams as well as board of directors.CREDENTIALS:➢ PharmD, PhD ➢ Post-doctoral fellowship in Immunology at the National Institutes of Health with a focus on cytokine biology. ➢ Author of over 30 peer-reviewed publications in the areas of immunology, oncology, virology, and neurological disease. ➢ Co-inventor of Bioniz platform technology that covers over 45 patents EXECUTIVE AND FOUNDER OF 2 SUCCESSFUL BIOTECH COMPANIES:» Charted the roadmap for product development, operations, and marketing for Dermaheal USA Corp, » Co-invented novel platform technology for Bioniz Therapeutics and led the clinical development for its assets. Recruited top talent, raised capital, and closed M&A deal for its first asset. . Board member since company’s inception.CORE VALUES:★ Entrepreneurship★ Innovation★ Integrity★ Perseverance★ Collaboration★ Growth★ DiscoveryRESEARCH SPECIALTIES: Immunology | Cancer | Autoimmune | Inflammatory Disease | Cytokine Inhibitors | Peptide TherapiesScientific discovery | IP Strategy | Market Feasibility | Team Leadership | FDA Approvals | Clinical Trials | Team Building | Corporate Structure | Company Culture | Research & Development | Fundraising | M&A Negotiations | Regulatory Pathways | Patent Filings

Yutaka Tagaya

Scientific Co-Founder

Bioniz Therapeutics board members

Name & TitleBio
Nazli Azimi

Board Member

Nazli Azimi's LinkedIn

Scientist CEO with track record launching 2 successful biotech companies. Talent for translating scientific discovery into commercial opportunity with “pipeline in a product” strategy to create blockbuster market opportunities. Deep scientific knowledge in immunology, cancer, autoimmune/inflammatory diseases, and neuroimmunology. Dynamic and sought-after public speaker.» Guiding discovery teams to prioritize efforts in identifying attractive targets for creating highly valuable drug candidates.» Navigating the crowded intellectual property landscape and securing IP.» Raising funds from seed to institutional investors and strategic partners.» Negotiating licensing and M&A deals.» Understanding the FDA regulatory pathways and guiding interactions with the agency. » Attracting top talent to the executive and scientific teams and building a dynamic and fun culture.» Working effectively across finance, audit, clinical, and technical teams as well as board of directors.CREDENTIALS:➢ PharmD, PhD ➢ Post-doctoral fellowship in Immunology at the National Institutes of Health with a focus on cytokine biology. ➢ Author of over 30 peer-reviewed publications in the areas of immunology, oncology, virology, and neurological disease. ➢ Co-inventor of Bioniz platform technology that covers over 45 patents EXECUTIVE AND FOUNDER OF 2 SUCCESSFUL BIOTECH COMPANIES:» Charted the roadmap for product development, operations, and marketing for Dermaheal USA Corp, » Co-invented novel platform technology for Bioniz Therapeutics and led the clinical development for its assets. Recruited top talent, raised capital, and closed M&A deal for its first asset. . Board member since company’s inception.CORE VALUES:★ Entrepreneurship★ Innovation★ Integrity★ Perseverance★ Collaboration★ Growth★ DiscoveryRESEARCH SPECIALTIES: Immunology | Cancer | Autoimmune | Inflammatory Disease | Cytokine Inhibitors | Peptide TherapiesScientific discovery | IP Strategy | Market Feasibility | Team Leadership | FDA Approvals | Clinical Trials | Team Building | Corporate Structure | Company Culture | Research & Development | Fundraising | M&A Negotiations | Regulatory Pathways | Patent Filings

David Pyott

Chairman of The Board

Joe Kiani

Board Member

Eric Carter

Board Member

Michael Martin

Board Member

Bana Jabri

Board Member

Graham Cooper

Board Member

Ilan Zipkin

Board Member

Robert Gallo

Board Member

Thomas Loughran

Board Member

Bioniz Therapeutics executives FAQs

Zippia gives an in-depth look into the details of Bioniz Therapeutics, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Bioniz Therapeutics. The employee data is based on information from people who have self-reported their past or current employments at Bioniz Therapeutics. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Bioniz Therapeutics. The data presented on this page does not represent the view of Bioniz Therapeutics and its employees or that of Zippia.

Bioniz Therapeutics may also be known as or be related to BIONIZ, LLC, Bioniz, Bioniz Therapeutics and Bioniz Therapeutics, Inc.